Filing Details
- Accession Number:
- 0000899243-20-028512
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-10-16 17:00:08
- Reporting Period:
- 2020-08-21
- Accepted Time:
- 2020-10-16 17:00:08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1802665 | Harmony Biosciences Holdings Inc. | HRMY | Pharmaceutical Preparations (2834) | 822279923 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1821461 | Ii Trust Fund Marshman | 330 N. Wabash Ave, Suite 300 Chicago IL 60611 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-08-21 | 339,476 | $24.00 | 10,651,120 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- On September 4, 2020, the reporting person filed a Form 4 amendment that incorrectly stated the number of shares of common stock beneficially owned after the reported transaction. Following the transactions reported hereing, as of August 21, 2020, the reporting person owned 10,651,120 shares of Common Stock.